Judge Allows Case Alleging Violations Of Diet Drugs’ Trademarks To Move Forward

( March 11, 2025, 2:14 PM EDT) -- SEATTLE — A Washington federal judge agreed that state law claims filed against medical centers and two physicians who prescribe patients compounded versions of tirzepatide, an FDA-approved drug for diabetes and weight loss, are preempted by federal law but otherwise denied a motion to dismiss....